IPNivo Versus Thervatremi - Is There a Correlation of Toxicity and Treatment Benefit?

The main difference when one looks at the two study regimens is the duration of each agent. I think that certainly there is toxicity associated with CTL-4 inhibition. In a well-conducted study, there is a modest increase in likelihood of benefit from somebody who experiences an auto-immune toxicity.